Agendia to Present at BioCentury’s Future Leaders in the Biotech Industry Conference

HUNTINGTON BEACH, California and AMSTERDAM - Agendia, a world leader in molecular cancer diagnostics, today
announced that the Company is scheduled to present at the 16th Anniversary
“Future Leaders in the Biotech Industry” Conference on Thursday, April 2,
2009. Presented by BioCentury and Thomson Reuters, the Future Leaders
conference has built a reputation as a major biotech investment event,
matching strong companies with a select group of specialized institutional
investors, investment bankers, sellside/buyside analysts, and pharmaceutical
licensing executives.

Agendia’s BioCentury Presentation details are as follows:

Event: BioCentury / Thomson Financial “Future Leaders in the Biotech
Industry”
Presenter: Dr. Bernhard Sixt, President & CEO
When: Thursday, April 2, 2009 at 1:30 - 1:55 p.m.
Breakout Session: 1:55 - 2:55 p.m., Room 502
Where: Millennium Broadway Hotel, New York City, Room 502/303
Address: 145 West 44th Street, New York, NY, 10036

About Agendia

Agendia is at the forefront of the personalized medicine
revolution, striving to bring more effective, individualized treatments
within reach of patients. Building on a cutting edge genomics platform for
tumor gene expression profiling, the company’s tests aim to help physicians
more accurately tailor cancer treatments. The company markets four products,
with several new genomic tests under development. In addition, Agendia
collaborates with pharmaceutical companies to develop highly effective
personalized drugs in the area of oncology. Agendia is based in Huntington
Beach, California, and in Amsterdam, The Netherlands. For more information
please visit www.agendia.com.

Source: Agendia B.V.

Media contacts: Hans Herklots, Head of Corporate Communications, +31-20-462-1557 Office, +31-620-083-509 Cell, hans.herklots at agendia.com; Valerie Delva, Ricochet Public Relations, +1-212-679-3300 x131 Office, +1-917-975-3191 Cell, vdelva at ricochetpr.com